Aktas Zeynep, Ozdemir Zeydanli Ece, Uysal Betul Seher, Yigiter Ahmet
Department of Ophthalmology, Atilim University School of Medicine.
Private Practice, Eye Clinic.
J Glaucoma. 2022 Sep 1;31(9):751-756. doi: 10.1097/IJG.0000000000002063. Epub 2022 Jun 13.
Gonioscopy-assisted transluminal trabeculotomy (GATT) provides greater intraocular pressure (IOP) reduction in pseudoexfoliative glaucoma (PXG) than in primary open angle glaucoma (POAG) in the first year of surgery; however, the difference between groups equalizes in the long term.
To compare outcomes of GATT in eyes with POAG and PXG.
Single-center, retrospective, comparative case-series. A total of 202 eyes (91 eyes of POAG; 111 eyes of PXG) were included. GATT was performed as a standalone procedure or in combination with cataract extraction. Outcome measures were change in IOP and number of medications at all time points (1, 3, 6, 9, 12, 18, 24, and 36 mo after surgery), success rate (IOP reduction ≥20% from baseline or IOP between 6 and 21 mmHg, without further glaucoma surgery), and complication rate. Cumulative success probabilities were compared using Kaplan-Meier survival analyses.
The mean IOP decreased by 8.8 mmHg (34.4%) in the POAG group with a mean decrease of 2 glaucoma medications at final visit. In the PXG group, the mean IOP decreased by 12.8 mm Hg (44.6%) on 2.3 fewer medications. Mean IOP reduction was significantly higher in PXG than POAG at all time points up to 2-year visit ( P <0.05 for all), after which the difference was not significant. Cumulative success probability during the first year was significantly higher in PXG (97.6%) than in POAG (86.8%) ( P =0.01); no significant difference was found at 2-year ( P =0.07) and 3-year visits ( P =0.24).
GATT was safe and effectively reduced the IOP and medication burden in patients with POAG and PXG. In the first year after GATT, a significantly higher success rate was noted in PXG compared with POAG; however, in subsequent years, the success rate was similar at ~75%.
在手术的第一年,房角镜辅助经腔小梁切开术(GATT)降低假性剥脱性青光眼(PXG)眼压(IOP)的效果优于原发性开角型青光眼(POAG);然而,从长期来看,两组之间的差异趋于平衡。
比较GATT在POAG和PXG眼中的治疗效果。
单中心、回顾性、比较性病例系列研究。共纳入202只眼(POAG 91只眼;PXG 111只眼)。GATT作为独立手术或与白内障摘除术联合进行。观察指标为所有时间点(术后1、3、6、9、12、18、24和36个月)的眼压变化和用药数量、成功率(眼压较基线降低≥20%或眼压在6至21 mmHg之间,无需进一步青光眼手术)以及并发症发生率。使用Kaplan-Meier生存分析比较累积成功概率。
POAG组平均眼压降低8.8 mmHg(34.4%),末次随访时青光眼用药平均减少2种。PXG组平均眼压降低12.8 mmHg(44.6%),用药减少2.3种。在2年随访前的所有时间点,PXG组平均眼压降低均显著高于POAG组(所有P<0.05),此后差异无统计学意义。第一年的累积成功概率PXG组(97.6%)显著高于POAG组(86.8%)(P=0.01);2年(P=0.07)和3年随访时差异无统计学意义(P=0.24)。
GATT安全有效,可降低POAG和PXG患者的眼压及用药负担。GATT术后第一年,PXG组成功率显著高于POAG组;然而,在随后几年,成功率相似,约为75%。